title: Dopamine transporters decrease with age.
abstract: Postmortem studies have documented degeneration of dopamine cells with age, but the changes that occur in healthy aging individuals is less clear. The purpose of this study was to evaluate the extent to which age-induced changes in dopamine transporters occur in subjects with no evidence of motor impairment.
  
  
  METHODS
  We evaluated 23 right-handed healthy volunteers (age range 20-74 yr) using PET and [11C]d-threo-methylphenidate. The ratio of the distribution volume for [11C]d-threo-methylphenidate in striatum to that in cerebellum was used as model parameter for dopamine transporter availability (Bmax/Kd + 1).
  
  
  RESULTS
  Dopamine transporter availability was significantly lower in subjects > 40 yr of age than in those < 40 yr. Estimates of dopamine transporter availability showed a significant negative correlation with age both for the putamen (r = -0.72, p < 0.0001) and the caudate (r = -0.74, p < 0.0001). Dopamine transporter availability was higher in the left than in the right putamen but did not differ between the left and right caudate.
  
  
  CONCLUSIONS
  This study documents a 6.6% decrease per decade of life in striatal dopamine transporters of healthy volunteers.
authors.affiliation: Medical Department, Brookhaven National Laboratory, Upton, New York 11973, USA.
authors.forename: N D
authors.initials: ND
authors.lastname: Volkow
authors.forename: Y S
authors.initials: YS
authors.lastname: Ding
authors.forename: J S
authors.initials: JS
authors.lastname: Fowler
authors.forename: G J
authors.initials: GJ
authors.lastname: Wang
authors.forename: J
authors.initials: J
authors.lastname: Logan
authors.forename: S J
authors.initials: SJ
authors.lastname: Gatley
authors.forename: R
authors.initials: R
authors.lastname: Hitzemann
authors.forename: G
authors.initials: G
authors.lastname: Smith
authors.forename: S D
authors.initials: SD
authors.lastname: Fields
authors.forename: R
authors.initials: R
authors.lastname: Gur
mesh_terms: D000328:Adult; D000368:Aged; D000375:Aging / Q000378:metabolism*; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D001923:Brain Chemistry; D002250:Carbon Radioisotopes; D002352:Carrier Proteins / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins; D005260:Female; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D008774:Methylphenidate; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D014055:Tomography, Emission-Computed
chemical_list: D002250:Carbon Radioisotopes; D002352:Carrier Proteins; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D008774:Methylphenidate